New Zealand's Medsafe Grants Provisional Approval for Novavax'...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Feb. 4, 2022 /PRNewswire-AsiaNet/ -- -- Nuvaxovid(TM) is the first protein-based COVID-19 vaccine to receive provisional approval for distribution in New ZealandNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vacci...
Authors: LATEST ASIANET NEWS RELEASES